(Q34553184)

3 August 2017

Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol (English)

1 reference

3 August 2017

Quyyumi AA

1

1 reference

3 August 2017

Wright C

series ordinal

2

1 reference

3 August 2017

Mockus L

series ordinal

3

1 reference

3 August 2017

Fox KM

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 1984

1 reference

3 August 2017

1 reference

3 August 2017

289

1 reference

3 August 2017

6450

1 reference

3 August 2017

951-953

1 reference

Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Exacerbation of vasotonic angina pectoris by propranolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Pindolol and alprenolol in angina pectoris: a comparative clinical study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Acute influence of different beta-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1443147

Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris

27 October 2018

1 reference

12 December 2020

Role of coronary vasospasm in the pathogenesis of myocardial ischemia and angina pectoris

1 reference

12 December 2020

Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris

1 reference

12 December 2020

Randomized double-blind study of pindolol in patients with stable angina pectoris

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.289.6450.951

0 references

PMCID

1443147

1 reference

3 August 2017

1 reference